Compare NRIM & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NRIM | PACB |
|---|---|---|
| Founded | 1990 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 548.3M | 521.8M |
| IPO Year | 2002 | 2010 |
| Metric | NRIM | PACB |
|---|---|---|
| Price | $24.34 | $2.05 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 8 |
| Target Price | ★ $30.33 | $2.40 |
| AVG Volume (30 Days) | 132.6K | ★ 13.7M |
| Earning Date | 10-26-2026 | 11-04-2026 |
| Dividend Yield | ★ 2.79% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.29 | N/A |
| Revenue | ★ $255,581,000.00 | $93,468,000.00 |
| Revenue This Year | $1.17 | N/A |
| Revenue Next Year | $25.45 | $15.58 |
| P/E Ratio | $18.92 | ★ N/A |
| Revenue Growth | ★ 30.43 | 3.04 |
| 52 Week Low | $19.60 | $1.07 |
| 52 Week High | $30.82 | $3.44 |
| Indicator | NRIM | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 38.60 | 55.00 |
| Support Level | $23.74 | $1.27 |
| Resistance Level | $25.27 | $2.73 |
| Average True Range (ATR) | 0.51 | 0.28 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 38.40 | 34.31 |
Northrim BanCorp Inc is a bank holding company operating through three reportable segments: Community Banking, Home Mortgage Lending, and Specialty Finance. The Community Banking segment, which generates the majority of revenue, provides loan and deposit products to business and consumer customers in its market areas. The Home Mortgage Lending segment focuses on the origination and sale of mortgage loans for one-to-four family residential properties, mortgage loan servicing for certain loans sold, and investment in selected residential mortgage loans. The Specialty Finance segment provides factoring, asset-based lending, and alternative working capital solutions to small and medium-sized enterprises and includes SCF and Northrim Funding Services.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.